Correlation Between THC Therapeutics and Pharmadrug
Can any of the company-specific risk be diversified away by investing in both THC Therapeutics and Pharmadrug at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining THC Therapeutics and Pharmadrug into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between THC Therapeutics and Pharmadrug, you can compare the effects of market volatilities on THC Therapeutics and Pharmadrug and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in THC Therapeutics with a short position of Pharmadrug. Check out your portfolio center. Please also check ongoing floating volatility patterns of THC Therapeutics and Pharmadrug.
Diversification Opportunities for THC Therapeutics and Pharmadrug
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between THC and Pharmadrug is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding THC Therapeutics and Pharmadrug in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmadrug and THC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on THC Therapeutics are associated (or correlated) with Pharmadrug. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmadrug has no effect on the direction of THC Therapeutics i.e., THC Therapeutics and Pharmadrug go up and down completely randomly.
Pair Corralation between THC Therapeutics and Pharmadrug
Given the investment horizon of 90 days THC Therapeutics is expected to generate 8.4 times more return on investment than Pharmadrug. However, THC Therapeutics is 8.4 times more volatile than Pharmadrug. It trades about 0.2 of its potential returns per unit of risk. Pharmadrug is currently generating about 0.04 per unit of risk. If you would invest 0.05 in THC Therapeutics on September 12, 2024 and sell it today you would earn a total of 0.02 from holding THC Therapeutics or generate 40.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 95.45% |
Values | Daily Returns |
THC Therapeutics vs. Pharmadrug
Performance |
Timeline |
THC Therapeutics |
Pharmadrug |
THC Therapeutics and Pharmadrug Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with THC Therapeutics and Pharmadrug
The main advantage of trading using opposite THC Therapeutics and Pharmadrug positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if THC Therapeutics position performs unexpectedly, Pharmadrug can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmadrug will offset losses from the drop in Pharmadrug's long position.THC Therapeutics vs. Grey Cloak Tech | THC Therapeutics vs. CuraScientific Corp | THC Therapeutics vs. Love Hemp Group | THC Therapeutics vs. Greater Cannabis |
Pharmadrug vs. 4Front Ventures Corp | Pharmadrug vs. Khiron Life Sciences | Pharmadrug vs. BellRock Brands | Pharmadrug vs. Elixinol Global |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |